📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Noven Pharmaceuticals

1.1 - Company Overview

Noven Pharmaceuticals Logo

Noven Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty prescription pharmaceutical products, engaged in the research, development, manufacture, marketing and sale of these products.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Noven Pharmaceuticals

Centessa Pharmaceuticals Logo

Centessa Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies and platforms, including SerpinPC, a biologic for hemophilia that inhibits activated protein C to reduce bleeding; an Orexin Receptor 2 agonist program for sleep-wake disorders; the LockBody technology platform designed to enhance immuno-oncology by selectively targeting the tumor microenvironment; and LB101, a conditionally tetravalent PD-L1 X CD47 bispecific monoclonal antibody for advanced solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Centessa Pharmaceuticals company profile →
Adello Biologics Logo

Adello Biologics

HQ: United States Website
  • Description: Provider of high-quality, affordable biosimilars, leveraging science-led innovation to accelerate development and drive manufacturing efficiency for patients worldwide; headquartered in Piscataway, NJ and led by industry veterans.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adello Biologics company profile →
Axys Pharmaceuticals Logo

Axys Pharmaceuticals

HQ: United States Website
  • Description: Provider of discovery, design, and development services for therapeutic small molecules addressing significant markets with major unmet medical needs; collaborates with large pharmaceutical companies to discover therapeutics for chronic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axys Pharmaceuticals company profile →
The Medicines Company Logo

The Medicines Company

HQ: United States Website
  • Description: Provider of innovative, cost-effective medicines to the worldwide hospital marketplace, focused on advancing treatment of critical care patients. Markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full The Medicines Company company profile →
Roivant Logo

Roivant

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and healthcare technologies, developing VTAMA (tapinarof) cream for plaque psoriasis and atopic dermatitis in adults and children 2+, Brepocitinib (TYK2/JAK1) for dermatomyositis and non-infectious uveitis, IMVT-1402 (FcRn inhibitor) for autoimmune diseases including Graves' disease, Namilumab for sarcoidosis, and Mosliciguat for pulmonary hypertension associated with interstitial lung disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Roivant company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Noven Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Noven Pharmaceuticals

2.2 - Growth funds investing in similar companies to Noven Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Noven Pharmaceuticals

4.2 - Public trading comparable groups for Noven Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Noven Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Noven Pharmaceuticals

What does Noven Pharmaceuticals do?

Noven Pharmaceuticals is a provider of specialty prescription pharmaceutical products, engaged in the research, development, manufacture, marketing and sale of these products.

Who are Noven Pharmaceuticals's competitors?

Noven Pharmaceuticals's competitors and similar companies include Centessa Pharmaceuticals, Adello Biologics, Axys Pharmaceuticals, The Medicines Company, and Roivant.

Where is Noven Pharmaceuticals headquartered?

Noven Pharmaceuticals is headquartered in United States.

How many employees does Noven Pharmaceuticals have?

Noven Pharmaceuticals has 1,000 employees 🔒.

When was Noven Pharmaceuticals founded?

Noven Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Noven Pharmaceuticals in?

Noven Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Noven Pharmaceuticals

Who are the top strategic acquirers in Noven Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Noven Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Noven Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Noven Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Noven Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Noven Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Noven Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Noven Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Noven Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Noven Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Noven Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Noven Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Noven Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Noven Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Noven Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Noven Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Noven Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Noven Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Noven Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Noven Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Noven Pharmaceuticals